Guided Sausage Technique in Bone Regeneration As a Novel Digital Work Flow (RCT)

September 27, 2024 updated by: Mona Al-Ahmady El-Meligy, Tanta University

Innovative Approach in Guided Bone Regeneration Using Digitally Designed Surgical Guide

The goal of this clinical trial is to compare amount of bone resorption and flap dehiscence following guided bone regeneration with or without digitally designed surgical guide. The main questions it aims to answer are:

  • Does it differ in amount of bone resorption between the conventional and digital guided bone regeneration?
  • What is the difference between conventional and digital protocols regarding flap dehiscence following guided bone regeneration? Researchers will compare digital guided versus conventional technique to choose adequately which protocol to use.

Participants will:

  • Receive guided bone regeneration around implant
  • Visit the clinic after 2,7,14 days for detection any signs of flap dehiscence
  • Bone gain and bone density will be assessed after 6 months

Study Overview

Detailed Description

Twenty sites with ridge defects will be recruited for this study. All investigations will be carried out in accordance with the 1975 Helsinki Declaration, as revised in 2013 for clinical approval. The purpose of the present study will be explained to the patients and informed consents will be obtained . Sites were randomly divided into 2 treatment groups .10 sites will be treated with bone graft (50%autogenous mixed with 50%xenograft) covered with bilayer collagen membrane without use of guide & 10 sites will receive the same treatment except it will be guided using digitally designed guide. Membranes in both groups will be stabilized by tacks. Following clinical parameters will be recorded: the wound opening of buccolingual distance between sutured flap margins with a UNC periodontal probe to the nearest millimeter at 2, 7 and 14 days, flap dehiscence. Also, bone gain and bone density will be assessed using cone beam computed tomography (CBCT) at baseline and 6 months post-surgery. The collected data was statistically analyzed at the different follow up periods.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tanta, Egypt
        • faculty of dentistry Tanta university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • medium horizontal ridge defect according to clone classification
  • must have a general health showing no contraindications for surgery
  • must be at least 35 years old
  • patients also have adequate soft tissue thickness and width of keratinized gingiva

Exclusion Criteria:

  • no sign of uncontrolled systemic diseases
  • non smoker
  • not pregnant
  • sever ridge deficient
  • patients below 18 years old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: conventional guided bone regeneration
a medium horizontal ridge defect will receive bone graft and covered with membrane
10 sites with medium horizontal ridge defect will be treated with bone graft (50%autogenous mixed with 50%xenograft) covered with bilayer collagen membrane stabilized by tacks
Active Comparator: digital guided bone regeneration
digital designed guide will be used in a medium horizontal ridge defect to place bone graft and covered with membrane
10 sites with medium horizontal ridge defect will be treated with bone graft (50%autogenous mixed with 50%xenograft) placed by digital designed guide covered with bilayer collagen membrane stabilized by tacks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
flap dehiscence
Time Frame: 14 days
the flap dehiscence will be assessed using a UNC periodontal probe through the the wound opening of buccolingual distance between sutured flap margins
14 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
bone gain
Time Frame: 6 months
bone gain will be assessed using cone beam computed tomography (CBCT)
6 months
bone denisty
Time Frame: 6 months
cone beam computed tomography (CBCT) will be used to asses bone density
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bassem nabil elfahl, assistant professor, faculty of dentistry Tanta university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2024

Primary Completion (Estimated)

September 24, 2024

Study Completion (Estimated)

October 20, 2024

Study Registration Dates

First Submitted

September 26, 2024

First Submitted That Met QC Criteria

September 27, 2024

First Posted (Actual)

October 1, 2024

Study Record Updates

Last Update Posted (Actual)

October 1, 2024

Last Update Submitted That Met QC Criteria

September 27, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • #R-OMPDR- 6-24-3122

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Digital Guided Bone Regeneration

Clinical Trials on conventional guided bone regeneration

Subscribe